Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Finding a travel credit card with no annual fee can be rewarding. Learn what features matter most to maximize your travel benefits.
19,690 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Investors who want clarity from SPX Technologies can decode the SPXC earnings transcript. This guide translates the n...
Concentra's Q4 2025 results shed light on its growth engine and profitability. This article breaks down the numbers, ...
Sotera Health has delivered a solid return over the last 12 months. Yet a sizable fund recently unloaded millions of ...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...
Microsoft’s stock has faced a rough start this year, stirring questions about value, timing, and long-term fit. This ...
A top executive recently disclosed selling a sizable block of Qualys stock. This article explains how to interpret in...
Oil markets wrestle with tight supply, uneven demand, and policy shifts as OPEC+ keeps cuts and U.S. shale expands. H...
This article breaks down MSGM earnings and what investors should watch in motorsport games. Learn how revenue streams...
Shay Capital reduced its PureCycle stake in the latest 13F filing, prompting questions about the stock's future. This...
The Nasdaq may be hovering near a correction, but smart planning helps investors navigate volatility. Here are four e...